Overview

Clinical Trial Management Systems Market is forecasted to value over USD 2.0 billion by 2028 end and register a CAGR of 14.5% from the forecast period 2021-2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Clinical Trial Management Systems Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.

According to the research study conducted by FutureWise research analysts, the Clinical Trial Management Systems Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Clinical Trial Management Systems Market are :

• ERT    
• Medidata Solutions
• PAREXEL International
• BioClinica
• Bio-Optronics  
• eClinforce  
• Merge Healthcare  
• DataTrak
• Veeva Systems
• DSG Inc.
• IBM 
• MasterControl 
• Advarra Technology Solutions 
• MedNet Solutions 
• ArisGlobal 
(Note: The list of the major players will be updated with the latest market scenario and trends)

Clinical Trial Management Systems Market Segmentation:

By Product Type

• Enterprise CTMS
• Site CTMS

By Delivery Mode

• Web-Based (Hosted) CTMS
• Licensed Enterprise (On Premise) CTMS
• Cloud-Based (SaaS) CTMS

By Component

• Software
• Service

By End User

• Large Pharma-biotech Companies
• CROs
• Medical Device Manufacturers
• Small & Mid-sized Pharma-biotech Companies
• Other End Users

By Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Clinical Trial Management Systems Market by product type, by delivery mode, by component, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Clinical Trial Management Systems Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Clinical Trial Management Systems Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Clinical Trial Management Systems Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Clinical Trial Management Systems Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies

7. Global Clinical Trial Management Systems Market, By Product Type Historical Analysis and Forecast 2021-2028 (USD Million)
        7.1. Enterprise CTMS
        7.2. Site CTMS
8. Global Clinical Trial Management Systems Market, By Delivery Mode Historical Analysis and Forecast 2021-2028 (USD Million)
         8.1 Web-Based (Hosted) CTMS
         8.2 Licensed Enterprise (On Premise) CTMS
         8.3 Cloud-Based (SaaS) CTMS
9. Global Clinical Trial Management Systems Market, By Component Historical Analysis and Forecast 2021-2028 (USD Million)
        9.1. Software
        9.2. Service
10. Global Clinical Trial Management Systems Market, By End User Historical Analysis and Forecast 2021-2028 (USD Million)
        10.1. Large Pharmaceutical Companies
        10.2. CROs
        10.3. Medical Device Manufacturers
        10.4. Small & Mid-sized Pharma-biotech Companies
        10.5. Other End Users
11. North America Clinical Trial Management Systems Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2021-2028 
12. Latin America Clinical Trial Management Systems Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2021-2028  
13. Europe Clinical Trial Management Systems Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2021-2028
14. Asia Pacific Clinical Trial Management Systems Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028
15. Middle East and Africa Clinical Trial Management Systems Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2021-2028           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    16.1. ERT    
            16.1.1. Company Overview
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2. Medidata Solutions
            16.2.1. Company Overview 
            16.2.2. Product Portfolio
            16.2.3. SWOT Analysis
            16.2.4. Financial Overview
            16.2.5. Strategic Overview
    16.3. PAREXEL International
            16.3.1. Company Overview 
            16.3.2. Product Portfolio
            16.3.3. SWOT Analysis
            16.3.4. Financial Overview
            16.3.5. Strategic Overview
    16.4. BioClinica
            16.4.1. Company Overview 
            16.4.2. Product Portfolio
            16.4.3. SWOT Analysis
            16.4.4. Financial Overview
            16.4.5. Strategic Overview
    16.5. Bio-Optronics  
            16.5.1. Company Overview 
            16.5.2. Product Portfolio
            16.5.3. SWOT Analysis
            16.5.4. Financial Overview
            16.5.5. Strategic Overview
    16.6. eClinforce  
            16.6.1. Company Overview 
            16.6.2. Product Portfolio
            16.6.3. SWOT Analysis
            16.6.4. Financial Overview
            16.6.5. Strategic Overview
    16.7. Merge Healthcare  
            16.7.1. Company Overview
            16.7.2. Product Portfolio
            16.7.3. SWOT Analysis
            16.7.4. Financial Overview
            16.7.5. Strategic Overview
    16.8. DataTrak
            16.8.1. Company Overview
            16.8.2. Product Portfolio
            16.8.3. SWOT Analysis
            16.8.4. Financial Overview
            16.8.5. Strategic Overview
    16.9. Veeva Systems
            16.9.1. Company Overview
            16.9.2. Product Portfolio
            16.9.3. SWOT Analysis
            16.9.4. Financial Overview
            16.9.5. Strategic Overview
    16.10. DSG Inc.
            16.10.1. Company Overview 
            16.10.2. Product Portfolio
            16.10.3. SWOT Analysis
            16.10.4. Financial Overview
            16.10.5. Strategic Overview
    16.11.IBM 
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview      
    16.12.MasterControl 
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview
    16.13.Advarra Technology Solutions 
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview
    16.14.MedNet Solutions 
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview 
    16.15.ArisGlobal
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview 
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures